@article{2dd9540e26344e8689fb383907799117,
title = "Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno et al",
keywords = "antirheumatic agents, cardiovascular diseases, hydroxychloroquine",
author = "Liew, {Jean W.} and Graef, {Elizabeth R.} and Sparks, {Jeffrey A.} and Kim, {Alfred Hyoungju}",
note = "Funding Information: Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute, and the R. Bruce and Joan M. Mickey Research Scholar Fund as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum. AHK reports grants from NIH/NIAMS and Rheumatology Research Foundation and personal fees from Exagen Diagnostics, Inc. and GlaxoSmithKline.",
year = "2022",
month = aug,
day = "1",
doi = "10.1136/annrheumdis-2020-218432",
language = "English",
volume = "81",
pages = "E155",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
number = "8",
}